“SGLT2 inhibitors for type 2 diabetes: how efficient are they in the analytic and anthropometric control?”, Rev Port Med Geral Fam, vol. 40, no. 1, pp. 41–7, Feb. 2024, doi: 10.32385/rpmgf.v40i1.13769.